Literature DB >> 15964709

Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study.

Nadia N Laack1, Paul D Brown, Robert J Ivnik, Alfred F Furth, Karla V Ballman, Julie E Hammack, Robert M Arusell, Edward G Shaw, Jan C Buckner.   

Abstract

PURPOSE: To evaluate the effects of cranial radiotherapy (RT) on cognitive function in patients with supratentorial low-grade glioma. METHODS AND MATERIALS: Twenty adult patients with supratentorial low-grade glioma were treated with 50.4 Gy (10 patients) or 64.8 Gy (10 patients) localized RT. The patients then were evaluated with an extensive battery of psychometric tests at baseline (before RT) and at approximately 18-month intervals for as long as 5 years after completing RT. To allow patients to serve as their own controls, cognitive performance was evaluated as change in scores over time. All patients underwent at least two evaluations.
RESULTS: Baseline test scores were below average compared with age-specific norms. At the second evaluation, the groups' mean test scores were higher than their initial performances on all psychometric measures, although the improvement was not statistically significant. No changes in cognitive performance were seen during the evaluation period when test scores were analyzed by age, treatment, tumor location, tumor type, or extent of resection.
CONCLUSIONS: Cognitive function was stable after RT in these patients evaluated prospectively during 3 years of follow-up. Slight improvements in some cognitive areas are consistent with practice effects attributable to increased familiarity with test procedures and content.

Entities:  

Mesh:

Year:  2005        PMID: 15964709     DOI: 10.1016/j.ijrobp.2005.04.016

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  48 in total

1.  Phase I trial of sorafenib in patients with recurrent or progressive malignant glioma.

Authors:  L B Nabors; J G Supko; M Rosenfeld; M Chamberlain; S Phuphanich; T Batchelor; S Desideri; X Ye; J Wright; S Gujar; S A Grossman
Journal:  Neuro Oncol       Date:  2011-09-27       Impact factor: 12.300

2.  Stereotactic radiation therapy for progressive residual pilocytic astrocytomas.

Authors:  Karlo J Lizarraga; Alessandra Gorgulho; Steve P Lee; Glenn Rauscher; Michael T Selch; Antonio A F DeSalles
Journal:  J Neurooncol       Date:  2012-05-27       Impact factor: 4.130

Review 3.  Radiation, chemotherapy, and symptom management in cancer-related cognitive dysfunction.

Authors:  Christopher Loiselle; Jason Rockhill
Journal:  Curr Pain Headache Rep       Date:  2009-08

4.  Diffusion tensor imaging predicts cognitive function change following partial brain radiotherapy for low-grade and benign tumors.

Authors:  Christopher H Chapman; Tong Zhu; Mohamad Nazem-Zadeh; Yebin Tao; Henry A Buchtel; Christina I Tsien; Theodore S Lawrence; Yue Cao
Journal:  Radiother Oncol       Date:  2016-07-11       Impact factor: 6.280

Review 5.  Indications for Treatment: Is Observation or Chemotherapy Alone a Reasonable Approach in the Management of Low-Grade Gliomas?

Authors:  Lauren R Schaff; Andrew B Lassman
Journal:  Semin Radiat Oncol       Date:  2015-02-23       Impact factor: 5.934

Review 6.  Investigation of cognitive impairments in people with brain tumors.

Authors:  Anna Rita Giovagnoli
Journal:  J Neurooncol       Date:  2012-03-06       Impact factor: 4.130

7.  The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma.

Authors:  Ryan S Youland; Cole R Kreofsky; David A Schomas; Paul D Brown; Jan C Buckner; Nadia N Laack
Journal:  J Neurooncol       Date:  2017-08-23       Impact factor: 4.130

8.  Cognitive and brain structural changes in long-term oligodendroglial tumor survivors.

Authors:  Nuria Cayuela; Esteban Jaramillo-Jiménez; Estela Càmara; Carles Majós; Noemi Vidal; Anna Lucas; Miguel Gil-Gil; Francesc Graus; Jordi Bruna; Marta Simó
Journal:  Neuro Oncol       Date:  2019-11-04       Impact factor: 12.300

9.  Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis.

Authors:  Michela Buglione; Sara Pedretti; Stefano Gipponi; Alice Todeschini; Ludovica Pegurri; Loredana Costa; Laura Donadoni; Salvatore Grisanti; Marco Fontanella; Roberto Liserre; Fabio Facchetti; Alessandro Padovani; Stefano Maria Magrini
Journal:  Radiol Med       Date:  2013-12-03       Impact factor: 3.469

10.  Longitudinal cognitive follow-up in low grade gliomas.

Authors:  Denise D Correa; Weiji Shi; Howard T Thaler; Angeles M Cheung; Lisa M DeAngelis; Lauren E Abrey
Journal:  J Neurooncol       Date:  2007-10-10       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.